Muthusamy Shanmugam - 29 Feb 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
29 Feb 2024
Transactions value $
-$75,926
Form type
4
Filing time
01 Mar 2024, 17:18:27 UTC
Previous filing
16 Feb 2024
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$75.9K -1.12K -1.61% $67.67 68.7K 29 Feb 2024 Direct F1
holding ANIP Common Stock 883K 29 Feb 2024 Held by Esjay LLC F2
holding ANIP Common Stock 5K 29 Feb 2024 Held by SS Pharma LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported.
F2 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F3 The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.